Position in SRRK
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$6,754,660
+$697,559 QoQ
Shares Held
122,812
-0.3% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#80
of 304 holders
Holding Since
Dec 2025
3 quarters on record
Common Shares in SRRK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026iA Global Asset Management Inc. holds $65,869,964 across 14 Biotechnology names. SRRK ranks #3 (10.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
30,054 | $14,928,723 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
20,154 | $12,566,825 | |
| 3 | SRRK |
Scholar Rock Holding Corp
This page
|
122,812 | $6,754,660 | |
| 4 | LEGN |
Legend Biotech Corp
|
211,135 | $6,097,578 | |
| 5 | ARGX |
Argenx SE
|
5,960 | $5,529,509 | |
| 6 | ZBIO |
Zenas BioPharma, Inc.
|
215,130 | $5,459,999 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
17,693 | $5,326,123 | |
| 8 | IRON |
Disc Medicine, Inc.
|
66,023 | $4,828,922 |
All Filings in SRRK
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,754,660 | 122,812 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $6,057,101 | 123,212 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $5,430,131 | 123,272 | Shares | Sole | 2026-02-05 | |
| No filing history on record for this holder in this stock. | ||||||